诺华制药(NVS) - 2023 Q2 - Quarterly Report

Novartis Second Quarter and Half Year 2023 Condensed Interim Financial Report – Supplementary Data | INDEX | Page | | --- | --- | | GROUP AND DIVISIONAL OPERATING PERFORMANCE | | | Group | 3 | | Innovative Medicines | 7 | | Sandoz | 13 | | CASH FLOW AND GROUP BALANCE SHEET | 15 | | INNOVATION REVIEW | 18 | | CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS | | | Consolidated income statements | 21 | | Consolidated statements of comprehensive income | 23 | | Consolidated balance sheets | 24 | | Consolidat ...